Cargando…

Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

BACKGROUND: Although trastuzumab provides significant clinical benefit for HER2-positive breast cancers, responses are limited by the emergence of resistance. Recent evidence suggests that long noncoding RNAs (lncRNAs) play important roles in tumorigenesis and chemoresistance. However, the regulator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Mingli, Gu, Yuanting, Lu, Pengwei, Li, Jingyi, Cao, Hui, Li, Xiangke, Qian, Xueke, Yu, Chao, Yang, Yunqing, Yang, Xue, Han, Na, Dou, Dongwei, Hu, Jianguo, Dong, Huaying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001272/ https://www.ncbi.nlm.nih.gov/pubmed/32020881 http://dx.doi.org/10.1186/s12943-020-1145-5

Ejemplares similares

Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
por: Han, Mingli, et al.
Publicado: (2022)

Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer
por: Han, Mingli, et al.
Publicado: (2020)

Retraction Note: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer
por: Han, Mingli, et al.
Publicado: (2023)

LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma
por: Hao, Fengqin, et al.
Publicado: (2018)

LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells
por: Shi, Xiuhui, et al.
Publicado: (2017)

Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2019)

LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p
por: Dang, Yuan, et al.
Publicado: (2021)

Correction: LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells
por: Shi, Xiuhui, et al.
Publicado: (2022)

Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer
por: Li, Zhouxiao, et al.
Publicado: (2019)

Silencing of lncRNA AFAP1-AS1 suppressed lung cancer development by regulatory mechanism in cis and trans
por: Peng, Baoying, et al.
Publicado: (2017)

Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
por: Dong, Huaying, et al.
Publicado: (2019)

Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
por: Dong, Huaying, et al.
Publicado: (2021)

Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
por: Dong, Huaying, et al.
Publicado: (2022)

Cloning and characterization of the putative AFAP1-AS1 promoter region
por: Wei, Fang, et al.
Publicado: (2019)

High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis
por: Bo, Hao, et al.
Publicado: (2018)

Bidirectional interaction of lncRNA AFAP1-AS1 and CRKL accelerates the proliferative and metastatic abilities of hepatocarcinoma cells
por: Abdul, Sattar, et al.
Publicado: (2020)

Silencing lncRNA AFAP1-AS1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma Cells via Regulating the miR-498/VEGFA Axis
por: Shen, Wenhao, et al.
Publicado: (2020)

Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway
por: Dou, Dongwei, et al.
Publicado: (2020)

Silencing of LncRNA AFAP1-AS1 Inhibits Cell Proliferation in Oral Squamous Cancer by Suppressing CCNA2
por: Li, Tao, et al.
Publicado: (2021)

A Review on the Role of AFAP1-AS1 in the Pathoetiology of Cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

LncRNA AFAP1-AS1 Promotes the Progression of Colorectal Cancer through miR-195-5p and WISP1
por: Li, Yongsheng, et al.
Publicado: (2021)

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
por: Singer, Josef, et al.
Publicado: (2012)

The Tumorigenic Effect of lncRNA AFAP1‐AS1 is Mediated by Translated Peptide ATMLP Under the Control of m(6)A Methylation
por: Pei, Hailong, et al.
Publicado: (2023)

Long Noncoding RNA CAMTA1 Promotes Proliferation and Mobility of the Human Breast Cancer Cell Line MDA-MB-231 via Targeting miR-20b
por: Lu, Pengwei, et al.
Publicado: (2018)

Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma
por: Tang, Yanyan, et al.
Publicado: (2017)

LncRNA AFAP1-AS Functions as a Competing Endogenous RNA to Regulate RAP1B Expression by sponging miR-181a in the HSCR
por: Chen, Guanglin, et al.
Publicado: (2017)

Circ-AFAP1 promote clear cell renal cell carcinoma growth and angiogenesis by the Circ-AFAP1/miR-374b-3p/VEGFA signaling axis
por: Ou, Yuxi, et al.
Publicado: (2022)

SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway
por: Li, Fangyuan, et al.
Publicado: (2023)

Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer
por: Han, Xu, et al.
Publicado: (2016)

LncRNA AFAP1-AS Functions as a Competing Endogenous RNA to Regulate RAP1B Expression by sponging miR-181a in the HSCR: Erratum
por: Chen, Guanglin, et al.
Publicado: (2018)

Increased lncRNA AFAP1‐AS1 expression predicts poor prognosis in gastric cancer: Evidence from published studies and followed up verification
por: Duan, Fujiao, et al.
Publicado: (2022)

LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis
por: Zuo, Tao, et al.
Publicado: (2023)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022)

Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody
por: Wang, Chao, et al.
Publicado: (2017)

Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China
por: Liu, Rui-Hua, et al.
Publicado: (2017)

M2 Macrophage-Derived Exosomal lncRNA AFAP1-AS1 and MicroRNA-26a Affect Cell Migration and Metastasis in Esophageal Cancer
por: Mi, Xifeng, et al.
Publicado: (2020)

LncRNA AFAP1-AS1/miR-27b-3p/VEGF-C axis modulates stemness characteristics in cervical cancer cells
por: Xia, Meng, et al.
Publicado: (2021)

LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway
por: Ning, MingLiang, et al.
Publicado: (2021)

LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway
por: Shi, Deyao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nf2cmdsgto7iedqv4825mguvos